BioMost Stabilize™

BioMost Stabilize™

BioMost Stabilize™ supports advanced microbiome stabilization, mucosal immune resilience, and regulatory T cell pathway maintenance through a Bifidobacterium-dominant probiotic blend. The strains work together to:

• Support stabilization of microbiome composition after the Phase 2–3 metabolic transformation

• Assist in short-chain fatty acid production, particularly butyrate, that directly fuels regulatory T cell activity

• Provide mucosal immune resilience through gut-immune axis reinforcement

• Contribute to long-term FOXP3 regulatory pathway maintenance and immune homeostasis

Key Ingredients:

• Bifidobacterium longum (BB536) — a foundational Bifidobacterium strain associated with butyrate production, gut barrier integrity, and FOXP3+ Treg induction.

• Bifidobacterium infantis (M-63 equivalent) — supports mucosal immune tolerance and has been studied in connection with regulatory immune signaling pathways.

• Lactobacillus reuteri DSM 17938 — associated with anti-inflammatory cytokine balance and support for the gut-brain-immune axis.

• Bacillus coagulans (GBI-30, 6086) — a spore-forming strain that provides additional stability and contributes to microbiome diversity maintenance.

How It Works:

The organic ingredients are designed to work synergistically to:

• Deliver 60 Billion CFU of a Bifidobacterium-dominant blend selected specifically for its role in FOXP3+ Treg induction and gut-immune homeostasis.

• Stabilize the microbiome composition gains made during the early protocol phases, preventing reversion to the pre-protocol inflammatory microbiome pattern.

• Support butyrate production that serves as both an energy source for gut lining cells and a direct signal for regulatory T cell expansion.

Suggested Use: Take 2 capsules daily either on an empty stomach or 30 minutes before meals, or as directed by your healthcare practitioner. Refrigeration recommended after opening. Individual results may vary. 30 Servings Per Bottle